[Evaluation of response to treatment in chronic hepatitis C]

Gastroenterol Clin Biol. 2002 Apr:26 Spec No 2:B23-31.
[Article in French]
No abstract available

Publication types

  • Comparative Study
  • Consensus Development Conference
  • Review

MeSH terms

  • Alanine Transaminase / blood
  • Amantadine / administration & dosage
  • Amantadine / therapeutic use
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • Biopsy
  • Carcinoma, Hepatocellular / epidemiology
  • Carcinoma, Hepatocellular / etiology
  • Clinical Enzyme Tests
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Hepacivirus* / genetics
  • Hepacivirus* / isolation & purification
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / diagnosis
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / pathology
  • Hepatitis C, Chronic / virology*
  • Humans
  • Incidence
  • Interferons / administration & dosage
  • Interferons / therapeutic use
  • Liver / pathology
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / etiology
  • Meta-Analysis as Topic
  • Prospective Studies
  • RNA, Viral / blood
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Ribavirin / administration & dosage
  • Ribavirin / therapeutic use
  • Risk Factors
  • Time Factors
  • Transaminases / blood
  • Viremia / diagnosis*

Substances

  • Antiviral Agents
  • RNA, Viral
  • Ribavirin
  • Interferons
  • Amantadine
  • Transaminases
  • Alanine Transaminase